Pharma > Non-Regulated
VMLY&R HEALTH, Madrid / GILEAD ONCOLOGY / 2023
Overview
Credits
More Entries from Patient Engagement in Pharma
24 items
Patient Engagement
EUROFARMA, DENTSU CREATIVE
Innovative Use of Technology: Patient or Healthcare Professional
AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO), GREY
Disease Awareness & Understanding: Direct to Patient or Healthcare Professional
THE CHRYSALIS INITIATIVE, EVERSANA INTOUCH
Product or Service Promotion: Healthcare Professional
AstraZeneca, 21GRAMS
HORIZON THERAPEUTICS, AREA 23, AN IPG HEALTH NETWORK COMPANY
JOBST, PUBLICIS•POKE
MND ASSOCIATION, DEEPAI, AMYLYX PHARMACEUTICALS, AREA 23, AN IPG HEALTH NETWORK COMPANY
DISEASE AWARENESS, FCB HEALTH
Healthcare Professional Engagement
LENALIDOMIDE, FCB HEALTH EUROPE
NEXTMED HEALTH, KLICK HEALTH
BIOGEN, VMLY&R HEALTH
Unbranded Product or Service Promotion
NOVO NORDISK, HONEYTRAP
ASTRAZENECA, EDELMAN
MODERNA, HEARTS & SCIENCE
Product or Service Promotion: Direct to Patient
HEMLIBRA, 21GRAMS
EXELTIS LABORATORY, VMLY&R
GC AESTHETICS, BESWEET FILMS
CIONIC, FUSEPROJECT
More Entries from VMLY&R HEALTH
16 items
Data-enhanced Creativity
GILEAD ONCOLOGY, VMLY&R HEALTH
Good Health and Well-being
Data Storytelling
Data Visualisation
PKU FOUNDATION, VMLY&R HEALTH
Public Affairs & Lobbying
Single-market Campaign